Brentuximab Vedotin and Bendamustine for the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (ALCL)
Clinical trial NCT01657331 · COMPLETED
Trial details
- NCT number
- NCT01657331
- Sponsor
- Columbia University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2018-06-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.